ARSAKILIC ACID STARTUP FACT SHEET ' 1 . What Is Being Produced

Total Page:16

File Type:pdf, Size:1020Kb

ARSAKILIC ACID STARTUP FACT SHEET ' 1 . What Is Being Produced May 10, 1977 cc ARSAKILIC ACID STARTUP FACT SHEET • ' 1 . What Is Being Produced? The major portion of the equipment is devoted to the manufacture of crude arsanilic acid (TA) . The crude product ie then coverted into Carbarsone or purified arsanilic acid (AA-100). 2. Raw Materials Aniline (AN) A colorless oily liquid - virtually insoluble in vater. Arsenic Acid A colorless dense liquid. Perchloroethylene (PCE) A clear water-white liquid commonly used for dry- cleaning - insoluble in water. Caustic (25%) A strongly alkaline liquid. Hydrochloric Acid (HC1) A strongly acidic liquid, .— water-white. Nuchar SN „ .. j '....» A black powder used to purify* and decolorize. Solka Floe and Piasbestos Powdery solids used as filter aids. 3. Special nomenclature and Abbreviations • AA - Arsanilic Acid TA - Crude AA (Technical Arsanilic Acid) AN - Aniline PCE - Perchloroethylene AW - Aniline Vater (vater with 2% aniline) ML - Mother Liquors - the liquid recovered from a filtration. 300001 May 10. 1977 Page 2 ARSANILIC ACID STARTUP FACT SHEET (CONT'D) • f 4. Process Operations Reaction - chemical combining of two or more compounds to form a new compound or compounds. Extraction- the separation of two miscible liquids by the use of a solvent which preferentially dissolves one of them. Hydrolysis- a reaction with water ("hydro"). Stripping - the separation of a component from a mixture by boiling it away with the help of another solvent. Filtration- removal of a solid from a slurry (liquid and solid mix). (Centri- fugation) Crystallization - formation of a slurry (solid) by cooling a saturated solution. Concentration - reduction in the volume of a solution by evaporation of some of the excess solvent. Distillation - the separation of compounds by utilization of the difference £n boiling points (volatility). 5. Basic Chemistry .-» * -. • 1400C (a) Aniline & Arsenic Acid » *> Arsanilic Acid ' '••:>, (b) Arsanilic Acid & Aniline *>' DDAA & Water (by-product) 125°C (c) DDAA & Water • > Arsanilic Acid & Aniline Reactions (a) and (b) take place in the reactors in the presence of excess aniline. Reaction (c) is the reverse of (b) and takes place in the hydrolysis tank. in the presence of excess water. 300002 May 10, 1977 Page 3 ARSAKILIC ACID STARTUP FACT SHEET (CONT'D) «««M^.BW 6. Labor Assignments (Subject to Change) A £ Shift Leader Hank Kreieer John Hunsicker Russell Sc A Operators - Reactors Tom Boltz Jerry Guindon Luther Water Extraction • Umbenhaue Stills A Operators - FCE Extraction Greg Kiret Dennis Shumaker Mike Klinj Stills Tank Farm E Operators - Hydrolysis Frank Yocum Charles Moll Tom Strip McDovell Crystallization ML Concentration E Operators - Carbarsone Fat Dawson - Marcia Spitler Barry Frit AA-100 Dryers Waste Evaporation C Operators - Centrifuges Thinh Van Nguyen Don Feiffer Al Bucks Filter Fress „ Woody 'Arnold Fred Feters Waste Evaporation Waste Salts 7. Shift Schedule , -. • '.-;.» " ————————— Starting week of 5/16/77 and rotating thereafter. 12-8 C-Shif t —— 8- 4 A-Shift 4-12 B-Shift 8. Flant Organization Flant Manager •—————;—————— Harold M. Huffman Chemical Area Manager -——•——— Joseph Gallagher Arsenical Department Manager —— Richard Cortellini Safety Director -—————————- Frantz Dengler cc: R. Cortellini H. Kreiser R. Bright H. Mann J. Hunsicker R. Schott 300003 1 U:^_. ..„_...-- ———— .„ . A 1 r-l ~r ; : - ft) -s CO ' to ^J 0 Lz I ^J ' s 4J 0) CO Ijj i/i ^ ~ •" "•> ^ 9 jJ S *•" u ^"> — — • o O 10 o 00 J U- V CI "sJ; 1C "S1 3 : CO J § S — « J_ t4oJ g •H ~% cO ft f '•) ^to' M J *rl S (f U U >j r «-. — -1 -M-> 0- «• J-2 1 -*- 0 i 00 « H •H e- •0 X' U O ^ — r2- u i- S cS 1H L ^ u ' 1 •H f? j i 1 ce t~+ , 1 •H *Jft)-' 9 ft)to 4J CO j k ^ * 1- s?^ 'k ^ -«- 1 > • J *« •S ce & n n t(lu | to « •«• B •H u e £ 0 4r4 n 1 U E £ '— CO — M — o — o- n •rH •H ft) -5 s ce •O *•} V -O- « J -Ji e 1I CO ~s 1 •^ . t 4 , • j •1H' •H 0) ft) JU 4J • _^ _g -= O •H JJ ft) 4J JJ ^ 2 9- •1H "*" u r-l rLI 3 •i CO O g £ ^ (£ M < , P< "l-l o) ' —— •0 « e <3- — 1 u O • . •*p *H O « If t0 ft) 4J g C 2 5 CO -re in "-£ Ot iu 4J C 1- ft) '•1' *p P-i • -3 n 5 ^ — r -*0 1 e 0) • U o r ^O 4J ^ j , <••s •H -^O —t>- ? -JO ft) r-l ft) 1C ' (0 .-1 U •H 4J u } * i b1 4J t N u CO e^ ^ ^ -*>- & CO ft) • S. 1-I "5 ^ c!S to .. •H ^^ i -*o- li •H 4 •$ 1 8 S U n— < •o I cu u "? U > ^ • 1 0 & .J3 e *H u CO I rH s b3 1\b •H C i ^ .U | — w — i-l n ce w £ •|e •H 0) -b ft) 1 r i ' ' . 9 ^ 1 £ Pu tv H fc r U rH Je U O ,P 9 O ^ <s Is i J 3f f ^0^ ft) ft) 4J — c- 1 & «- — - i i ' 1 ...^ I I 1 1 •'-i- f-h: -H-t—. _. ^ 'ii-T'TTT\ !~! n I AM- r- so 1^,0 ,"70 i r i I «• L .Li-J\- -Rr-l-l i-hr 1 • ' • I• i ' rr i-Hj_. L- r^sL^.^yL -i rcmme'xuitjijs. J-U-L ! ! H rr /°r<r kxr&faroti 3 _|J J J T~T IM •• j / i , •;• i •*•_ -j- i i <i M-Hi i i.i — T i T -r ' T- 3 --§ _j_! :1 i I -hr i2E i! I i i Ti V- 'b-3/o 320' -5 -!- til, JSJ rh-i-.-i— T-33*. H-H—I- r--H f&CKlf SfOfACf I i. 300005 i _| I i I j i i ;.
Recommended publications
  • Arsinothricin, an Arsenic-Containing Non-Proteinogenic Amino Acid Analog of Glutamate, Is a Broad-Spectrum Antibiotic
    ARTICLE https://doi.org/10.1038/s42003-019-0365-y OPEN Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic Venkadesh Sarkarai Nadar1,7, Jian Chen1,7, Dharmendra S. Dheeman 1,6,7, Adriana Emilce Galván1,2, 1234567890():,; Kunie Yoshinaga-Sakurai1, Palani Kandavelu3, Banumathi Sankaran4, Masato Kuramata5, Satoru Ishikawa5, Barry P. Rosen1 & Masafumi Yoshinaga1 The emergence and spread of antimicrobial resistance highlights the urgent need for new antibiotics. Organoarsenicals have been used as antimicrobials since Paul Ehrlich’s salvarsan. Recently a soil bacterium was shown to produce the organoarsenical arsinothricin. We demonstrate that arsinothricin, a non-proteinogenic analog of glutamate that inhibits gluta- mine synthetase, is an effective broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria, suggesting that bacteria have evolved the ability to utilize the per- vasive environmental toxic metalloid arsenic to produce a potent antimicrobial. With every new antibiotic, resistance inevitably arises. The arsN1 gene, widely distributed in bacterial arsenic resistance (ars) operons, selectively confers resistance to arsinothricin by acetylation of the α-amino group. Crystal structures of ArsN1 N-acetyltransferase, with or without arsinothricin, shed light on the mechanism of its substrate selectivity. These findings have the potential for development of a new class of organoarsenical antimicrobials and ArsN1 inhibitors. 1 Department of Cellular Biology and Pharmacology, Florida International University, Herbert Wertheim College of Medicine, Miami, FL 33199, USA. 2 Planta Piloto de Procesos Industriales Microbiológicos (PROIMI-CONICET), Tucumán T4001MVB, Argentina. 3 SER-CAT and Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
    [Show full text]
  • APPENDIX G Acid Dissociation Constants
    harxxxxx_App-G.qxd 3/8/10 1:34 PM Page AP11 APPENDIX G Acid Dissociation Constants §␮ ϭ 0.1 M 0 ؍ (Ionic strength (␮ † ‡ † Name Structure* pKa Ka pKa ϫ Ϫ5 Acetic acid CH3CO2H 4.756 1.75 10 4.56 (ethanoic acid) N ϩ H3 ϫ Ϫ3 Alanine CHCH3 2.344 (CO2H) 4.53 10 2.33 ϫ Ϫ10 9.868 (NH3) 1.36 10 9.71 CO2H ϩ Ϫ5 Aminobenzene NH3 4.601 2.51 ϫ 10 4.64 (aniline) ϪO SNϩ Ϫ4 4-Aminobenzenesulfonic acid 3 H3 3.232 5.86 ϫ 10 3.01 (sulfanilic acid) ϩ NH3 ϫ Ϫ3 2-Aminobenzoic acid 2.08 (CO2H) 8.3 10 2.01 ϫ Ϫ5 (anthranilic acid) 4.96 (NH3) 1.10 10 4.78 CO2H ϩ 2-Aminoethanethiol HSCH2CH2NH3 —— 8.21 (SH) (2-mercaptoethylamine) —— 10.73 (NH3) ϩ ϫ Ϫ10 2-Aminoethanol HOCH2CH2NH3 9.498 3.18 10 9.52 (ethanolamine) O H ϫ Ϫ5 4.70 (NH3) (20°) 2.0 10 4.74 2-Aminophenol Ϫ 9.97 (OH) (20°) 1.05 ϫ 10 10 9.87 ϩ NH3 ϩ ϫ Ϫ10 Ammonia NH4 9.245 5.69 10 9.26 N ϩ H3 N ϩ H2 ϫ Ϫ2 1.823 (CO2H) 1.50 10 2.03 CHCH CH CH NHC ϫ Ϫ9 Arginine 2 2 2 8.991 (NH3) 1.02 10 9.00 NH —— (NH2) —— (12.1) CO2H 2 O Ϫ 2.24 5.8 ϫ 10 3 2.15 Ϫ Arsenic acid HO As OH 6.96 1.10 ϫ 10 7 6.65 Ϫ (hydrogen arsenate) (11.50) 3.2 ϫ 10 12 (11.18) OH ϫ Ϫ10 Arsenious acid As(OH)3 9.29 5.1 10 9.14 (hydrogen arsenite) N ϩ O H3 Asparagine CHCH2CNH2 —— —— 2.16 (CO2H) —— —— 8.73 (NH3) CO2H *Each acid is written in its protonated form.
    [Show full text]
  • Multi-Residue Determination of Organic Arsenical Drugs in Feeds by LC-MS/MS
    Multi-Residue Determination of Organic Arsenical Drugs in Feeds by LC-MS/MS Geneviève Grenier, Melanie Titley & Lise-Anne Prescott AAFCO Laboratory Methods and Services Committee meeting 2016-01-18 Background • Animal Feed Division of CFIA identified a high priority need for the determination of three organic arsenicals (arsanilic acid, roxarsone and nitarsone) at residue levels in animal feed • These are withdrawal drugs and are priority food contaminants • Current test methods are at guarantee levels greater than 10% minimum use rate • Therefore, current methods not well suited for residue or traceback testing • Requested feed residue LOQ of 1 mg/kg for all three organic arsenicals 2 Background • UHPLC-PDA Challenges • Extract were very dirty • Tried sample clean-up using Oasis MAX SPE • Still very dirty • HPLC Challenges • Compounds elute too easily • Analytical column must : retain and separate compounds, and give good peak shape • Analytical column : Phenomenex Onyx Monolithic C18 100 X 3.0mm 3 Background • LC/MS/MS method (positive mode) • Column: Phenomenex Onyx Monolithic C18 100 X 3.0mm • Linearity problems with Internal Standard (IS) • Internal standard – 4-hydroxyphenylarsonic acid • Peak area of the internal standard increased with increasing analyte concentration • Cause • 4-hydroxyphenyl arsanic acid co-elute with Arsanilic acid and have similar m/z 4 New method - summary • Liquid chromatography combined with atomic and molecular mass spectrometry for speciation of arsenic in chicken liver. Peng et. al., Journal of Chromatography
    [Show full text]
  • CHEM 301 Assignment #2 Provide Solutions to the Following Questions in a Neat and Well-Organized Manner
    CHEM 301 Assignment #2 Provide solutions to the following questions in a neat and well-organized manner. Reference data sources for any constants and state assumptions, if any. Due date: Thursday, Oct 20th, 2016 Attempt all questions. Only even numbers will be assessed. 1. A pond in an area affected by acid mine drainage is observed to have freshly precipitated Fe(OH)3(s) at pH 4. What is the minimum value of pe in this water? Use the appropriate pe-pH speciation diagram to predict the dominant chemical speciation of carbon, sulfur and copper under these conditions. 2. The solubility of FeS(s) in marine sediments is expected to be affected by the pH and the [H2S(aq)] in the surrounding pore water? Calculate the equilibrium concentration of Fe2+ (ppb) at pH 5 and pH 8, -3 assuming the H2S is 1.0 x 10 M. pKsp(FeS) = 16.84. + 2+ FeS(s) + 2 H (aq) ==== Fe (aq) + H2S 3. Boric acid is a triprotic acid (H3BO3); pKa1 = 9.24, pKa2 = 12.74 and pKa3 = 13.80. a) Derive an expression for the fractional abundance of H3BO3 as a function of pH b) Construct a fully labeled pH speciation diagram for boric acid over the pH range of 0 to 14 using Excel spreadsheet at a 0.2 pH unit interval. 4. At pCl- = 2.0, Cd2+ and CdCl+ are the only dominant cadmium chloride species with a 50% fractional abundance of each. + a) Calculate the equilibrium constant for the formation of CdCl (1). + - b) Derive an expression for the fractional abundance of CdCl as a function of [Cl ] and 1 – 4 for cadmium chloro species.
    [Show full text]
  • Inorganic Arsenic Compounds Other Than Arsine Health and Safety Guide
    OS INTERNATiONAL I'ROGRAMME ON CHEMICAL SAFETY Health and Safety Guide No. 70 INORGANIC ARSENIC COMPOUNDS OTHER THAN ARSINE HEALTH AND SAFETY GUIDE i - I 04 R. Q) UNEP UNITED NATIONS INTERNATIONAL ENVIRONMENT I'R( )GRAMME LABOUR ORGANISATION k\s' I V WORLD HEALTH ORGANIZATION WORLD HEALTH ORGANIZATION, GENEVA 1992 IPcs Other H EA LTH AND SAFETY GUIDES available: Aerytonitrile 41. Clii rdeon 2. Kekvau 42. Vatiadiuni 3 . I Bula not 43 Di meLhyI ftirmatnide 4 2-Buta101 44 1-Dryliniot 5. 2.4- Diehlorpheiioxv- 45 . Ac rylzi mule acetic Acid (2.4-D) 46. Barium 6. NIcihylene Chhride 47. Airaziiie 7 . ie,i-Buia nol 48. Benlm'.ie 8. Ep Ichioroli) Olin 49. Cap a 64 P. ls.ihutaiiol 50. Captaii I o. feiddin oeth N lene Si. Parai.tuat II. Tetradi ion 51 Diquat 12. Te nacelle 53. Alpha- and Betal-lexachloro- 13 Clils,i (lane cyclohexanes 14 1 kpia Idor 54. Liiidaiic IS. Propylene oxide 55. 1 .2-Diciilroetiiane Ethylene Oxide 5t. Hydrazine Eiulosiillaii 57. F-orivaldehydc IS. Die h lorvos 55. MLhyI Isobu I V I kcloiic IV. Pculaehloro1heiiol 59. fl-Flexaric 20. Diiiiethoaie 61), Endrin 2 1 . A iii in and Dick) 0in 6 I . I sh IIZiLI1 22. Cyperniellirin 62. Nicki. Nickel Caution I. and some 23. Quiiiloieiic Nickel Compounds 24. Alkthrins 03. Hexachlorocyclopeuladiene 25. Rsiiiethii ins 64. Aidicaib 26. Pyr rot ii,id inc Alkaloids 65. Fe nitrolhioit 27. Magnetic Fields hib. Triclilorlon 28. Phosphine 67. Acroleiii 29. Diiiiethyl Sull'ite 68. Polychlurinated hiphenyls (PCBs) and 30. Dc lianteth nil polyc h In ruiated letlilienyls (fs) 31.
    [Show full text]
  • National Center for Toxicological Research (NCTR) Science Advisory Board (SAB)
    National Center for Toxicological Research (NCTR) Science Advisory Board (SAB) November 2, 2016 Crowne Plaza 201 S. Shackleford Road Little Rock, AR 72211 TABLE OF CONTENTS FDA Center Perspectives 1 Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Center for Devices and Radiological Health Center for Tobacco Products Center for Veterinary Medicine Office of Regulatory Affairs Discussion of NCTR Research (SAB Members) 120 1 P R O C E E D I N G S Agenda Item: FDA Center Perspectives DR. PHILBERT: Good morning. Our first presentation in a series from our colleagues at FDA is from Carolyn, Center for Biologics Evaluation and Research. DR. WILSON: Good morning. Thank you. I am going to start with an overview of the products we regulate just to orient some of you who may be new on the advisory board. Then I will go into the priorities for our scientific research program, as well as some examples of ongoing and potential future collaborations with NCTR. We regulate what are called complex biologic products, so things like monoclonal antibodies and most recombinant proteins are regulated in the Center for Drugs. But we regulate things like blood, blood components and derivatives, vaccines both preventative and therapeutic, the novel areas like cell and gene therapies, including stem cells, and that does include things like CRISPR modification of cells. Certain human tissues, live biotherapeutics and, yes, that includes fetal transplantation, allergenic products which actually, although that is a single line, represents over 1200 different extracts that are used both for diagnosis 2 and treatment of allergies, and then certain related devices, as well.
    [Show full text]
  • Code Chemical P026 1-(O-Chlorophenyl)Thiourea P081 1
    Code Chemical P026 1-(o-Chlorophenyl)thiourea P081 1,2,3-Propanetriol, trinitrate (R) P042 1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)- P067 1,2-Propylenimine P185 1,3-Dithiolane-2-carboxaldehyde, 2,4-dimethyl-, O- [(methylamino)- carbonyl]oxime 1,4,5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexa- chloro-1,4,4a,5,8,8a,-hexahydro-, P004 (1alpha,4alpha, 4abeta,5alpha,8alpha,8abeta)- 1,4,5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexa- chloro-1,4,4a,5,8,8a-hexahydro-, P060 (1alpha,4alpha, 4abeta,5beta,8beta,8abeta)- P002 1-Acetyl-2-thiourea P048 2,4-Dinitrophenol P051 2,7:3,6-Dimethanonaphth [2,3-b]oxirene, 3,4,5,6,9,9 -hexachloro-1a,2,2a,3,6,6a,7,7a- octahydro-, (1aalpha,2beta,2abeta,3alpha,6alpha,6abeta,7 beta, 7aalpha)-, & metabolites 2,7:3,6-Dimethanonaphth[2,3-b]oxirene, 3,4,5,6,9,9- hexachloro-1a,2,2a,3,6,6a,7,7a- P037 octahydro-, (1aalpha,2beta,2aalpha,3beta,6beta,6aalpha,7 beta, 7aalpha)- P045 2-Butanone, 3,3-dimethyl-1-(methylthio)-, O-[methylamino)carbonyl] oxime P034 2-Cyclohexyl-4,6-dinitrophenol 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1- phenylbutyl)-, & salts, when present at P001 concentrations greater than 0.3% P069 2-Methyllactonitrile P017 2-Propanone, 1-bromo- P005 2-Propen-1-ol P003 2-Propenal P102 2-Propyn-1-ol P007 3(2H)-Isoxazolone, 5-(aminomethyl)- P027 3-Chloropropionitrile P047 4,6-Dinitro-o-cresol, & salts P059 4,7-Methano-1H-indene, 1,4,5,6,7,8,8-heptachloro- 3a,4,7,7a-tetrahydro- P008 4-Aminopyridine P008 4-Pyridinamine P007 5-(Aminomethyl)-3-isoxazolol 6,9-Methano-2,4,3-benzodioxathiepin, 6,7,8,9,10,10-
    [Show full text]
  • Chemical Equilibrium and Reaction Modeling of Arsenic and Selenium in Soils
    3 Chemical Equilibrium and Reaction Modeling of Arsenic and Selenium in Soils Sabine Goldberg CONTENTS Inorganic Chemistry of As and Se in Soil Solution .......................................... 66 Methylation and Volatilization Reactions ......................................................... 66 Precipitation-Dissolution Reactions .................................................................. 68 Oxidation-Reduction Reactions .......................................................................... 68 Adsorption-Desorption Reactions ..................................................................... 69 Modeling of Adsorption by Soils: Empirical Models ...................................... 70 Modeling of Adsorption by Soils: Constant Capacitance ModeL................ 72 Summary................................................................................................................ 86 References ............................................................................................................... 87 High concentrations of the trace elements arsenic (As) and selenium (Se) in soils pose a threat to agricultural production and the health of humans and animals. As is toxic to both plants and animals. Se, despite being an essential micronutrient for animal nutrition, is potentially toxic because the concentra­ tion range between deficiency and toxicity in animals is narrow. Seleniferous soils release enough Se to produce vegetation toxic to grazing animals. Such soils occur in the semiarid states of the western United
    [Show full text]
  • Bacterial Mechanisms of Toxicity and Resistance to Organoarsenicals
    Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 11-13-2020 Bacterial Mechanisms of Toxicity and Resistance to Organoarsenicals Luis D. Garbinski Florida International University, [email protected] Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Biochemistry Commons, Environmental Microbiology and Microbial Ecology Commons, and the Molecular Biology Commons Recommended Citation Garbinski, Luis D., "Bacterial Mechanisms of Toxicity and Resistance to Organoarsenicals" (2020). FIU Electronic Theses and Dissertations. 4549. https://digitalcommons.fiu.edu/etd/4549 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida BACTERIAL MECHANISMS OF TOXICITY AND RESISTANCE TO ORGANOARSENICALS A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in BIOMEDICAL SCIENCES by Luis D Garbinski 2020 To: Dean Robert Sackstein Herbert Wertheim College of Medicine This dissertation, written by Luis D Garbinski, and entitled Bacterial Mechanisms of Toxicity and Resistance to Organoarsenicals, having been approved in respect to style and intellectual content, is referred to you for judgement. We have read this dissertation and recommend that it be approved. _______________________________________ Irina Agoulnik _______________________________________ Jun-yong Choe _______________________________________ Krishnaswamy Jayachandran _______________________________________ Masafumi Yoshinaga, Co-Major Professor _______________________________________ Barry Rosen, Co-Major Professor Date of Defense: November 11, 2020 The dissertation of Luis D Garbinski is approved.
    [Show full text]
  • SDS US 1AB Version #: 07 Revision Date: 07-17-2019 Issue Date: 08-26-2013 1 / 9 Precautionary Statement Prevention Obtain Special Instructions Before Use
    SAFETY DATA SHEET 1. Identification Product identifier Arsenic acid Other means of identification SDS number 1AB Materion Code 1AB CAS number 7778-39-4 Synonyms ARSENIC ACID Manufacturer/Importer/Supplier/Distributor information Manufacturer Company name Materion Advanced Chemicals Inc. Address 407 N 13th Street 1316 W. St. Paul Avenue Milwaukee, WI 53233 United States Telephone 414.212.0257 E-mail [email protected] Contact person Laura Hamilton Emergency phone number Chemtrec 800.424.9300 2. Hazard(s) identification Physical hazards Not classified. Health hazards Acute toxicity, oral Category 2 Skin corrosion/irritation Category 1 Serious eye damage/eye irritation Category 1 Germ cell mutagenicity Category 2 Carcinogenicity Category 1A Reproductive toxicity Category 2 Specific target organ toxicity, repeated Classification not possible exposure Environmental hazards Hazardous to the aquatic environment, acute Category 1 hazard Hazardous to the aquatic environment, Category 1 long-term hazard OSHA defined hazards Not classified. Label elements Signal word Danger Hazard statement Fatal if swallowed. May cause cancer. Causes severe skin burns and eye damage. Causes serious eye damage. Toxic if inhaled. Suspected of causing genetic defects. May cause cancer. Suspected of damaging fertility or the unborn child. Very toxic to aquatic life. Very toxic to aquatic life with long lasting effects. Material name: Arsenic acid SDS US 1AB Version #: 07 Revision date: 07-17-2019 Issue date: 08-26-2013 1 / 9 Precautionary statement Prevention Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe mist/vapors. Do not breathe dust/fume/gas/mist/vapors. Wash thoroughly after handling.
    [Show full text]
  • Photooxidation of P-Arsanilic Acid in Aqueous Solution by UV/Persulfate Process
    applied sciences Communication Photooxidation of p-Arsanilic Acid in Aqueous Solution by UV/Persulfate Process Xiangyi Shen 1, Jing Xu 2,*, Ivan P. Pozdnyakov 3,4 and Zizheng Liu 5,* ID 1 Department of Environmental Science, School of Resource and Environmental Sciences, Wuhan University, Wuhan 430079, China; [email protected] 2 State Key Laboratory of Water Resources and Hydropower Engineering Science, Wuhan University, Wuhan 430072, China 3 Institute of Chemical Kinetics and Combustion, Institutskaya 3, 630090 Novosibirsk, Russia; [email protected] 4 Novosibirsk State University, Pirogova str. 2, 630090 Novosibirsk, Russia 5 School of Civil Engineering, Wuhan University, Wuhan 430072, China * Correspondence: [email protected] (J.X.); [email protected] (Z.L.) Received: 26 February 2018; Accepted: 4 April 2018; Published: 13 April 2018 Abstract: Used as a kind of feed additive, p-arsanilic acid can pose a potential risk to organisms when abandoned in the environment. The photodegradation of p-ASA was investigated under UV-C irradiation in the presence of persulfate (PS) in this work. The addition of PS facilitated the decomposition of p-ASA and notably, the presence of 50 mmol PS brought about a nearly complete mineralization after 3 h, while an insignificant total organic carbon (TOC) removal was observed − under UV irradiation (λ = 254 nm) only. Experimental results proved that sulfate radical (SO4• ) was responsible for the promotion effect. The cleavage of As-C bond released inorganic arsenic and caused the occurrence of various organic products, for example, hydroxybenzaldehyde, nitrobenzene, benzenediol sulfate, and biphenylarsinic acid. The application of PS with UV-C light may throw a light on thorough treatment for p-ASA containing wastewater.
    [Show full text]
  • Arsenic (As33)
    NANO3D SYSTEMS LLC 1110 NE Circle Blvd., ATAMI/Bldg. 11, Corvallis, Oregon 97330-4254 T 503-927-4766| F 541-758-9320| http://www.nano3dsystems.com Arsenic (As33) Properties Arsenic is a silvery-white metalloid with an atomic mass of 74.92 u. As has a density of 5.73 g/cm3, a melting point of 814 oC, and a Brinell hardness of 1440 MPa. The most common compounds have As in the +3 and +5 states, while it also exists in other oxidation states such as -3, -2, -1, +1, +2, +4. Its standard electrode potential in respect to As+3 is +0.3V. Though stable in dry air, arsenic forms a golden-bronze tarnish upon exposure to humidity which eventually becomes a black surface layer. Arsenic makes arsenic acid with concentrated nitric acid, arsenous acid with dilute nitric acid, and arsenic trioxide with concentrated sulfuric acid. It does not react with water, alkalis, or non-oxidizing acids. As is estimated to be at average concentration of 1.5 parts per million (ppm) in the Earth's crust. Plating Solutions Arsenic can be electrochemically deposited from aqueous electrolytes, containing in g/l: a) Example #1. Arsenic trioxide – 90, sodium hydroxide – 110 ml/l, potassium sodium tartrate tetrahydrate (Rochelle salt) - 80 with pH ~8 at temperature of 15-25 oC, current density of 10 – 20 mA/cm2 and current efficiency of ~100%. b) Example #2. Arsenic trioxide – 120, sodium cyanide – 3.7, sodium hydroxide – 120 at temperature of 15-25 oC and current density of 3 – 22 mA/cm2. Arsenic clectrodeposition can be also performed from choline chloride/ethylene glycol deep eutectic solvent [1].
    [Show full text]